Clinical Trial Update: A Study Comparing Adjuvant Alectinib Versus Adjuvant Platinum-Based Chemotherapy in Patients With ALK Positive Non-Small Cell Lung Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial comparing adjuvant alectinib to adjuvant platinum-based chemotherapy in ALK-positive non-small cell lung cancer; results were posted in August 202…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Alectinib (alectinib)
• Platinum-based chemotherapy (platinum-based chemotherapy)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Carcinoma, Non-Small-Cell Lung | Phase 3 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2024-08-26